Mark W. Meyer

Mark Meyer practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Mark Meyer's NPI, 1184644569, was assigned on July 20, 2006. Mark Meyer holds Pennsylvania license MD056854L.

Mark Meyer's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Mark Meyer's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Mark Meyer is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is Stull, Jarvis, and Spinola Internal Medicine Associates-UPMC. Dmand AI also links Mark Meyer to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Meyer practices, 6 sites in all. Vendor and product names are available with a free account.

Family medicine is Mark Meyer's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Mark Meyer is licensed in Pennsylvania.

CMS data shows 21 Medicare services from Mark Meyer across 1 procedure code in 2024, all of them office visits, for 42 Medicare patients. Medicare paid $1,698 for them. Every service was in an office.

CMS counts 42 Medicare patients who saw Mark Meyer in 2024. The largest group is 65 to 74, with 18 patients. 67% of them have high blood pressure, and 45% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Meyer's median patient age at 56, with 66% women.

In 2024, Mark Meyer wrote 3,198 Medicare Part D claims for 322 patients. 83% of them were for generic drugs. CMS names the drug for 2,585 of them, across 67 drugs with 11 or more claims each, at $266,609 in total drug cost. In 2023, CMS named 2,647 claims across 73 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Mark Meyer for performance year 2024, reported as part of a group. Mark Meyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Mark Meyer from 2 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $137.